Fat Loss + Lean Muscle Cycle: A popular stack for women includes Clenbutrol for thermogenic fat burning, Anvarol for lean ...

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it ...

Vincerx Pharma, Inc. (OTC Pink: VINC) today announced that the re-convened Special Meeting of Stockholders to consider a proposal to approve the liquidation and dissolution of Vincerx (the ...

NKGen is a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic NK cell therapeutics. NKGen is headquartered in Santa Ana, ...

NEW YORK, July 16, 2025 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE: TDOC), the global leader in virtual care, announced that it will release second quarter 2025 results on Tuesday, July 29, 2025, ...

The Series A-1 warrants have an exercise price of $1.90 per share, are exercisable upon issuance and expire five years thereafter. The short-term Series A-2 warrants have an exercise price of $1.90 ...

The Unit Shares and Warrants, and any securities issuable upon conversion or exercise thereof, are subject to a four-month hold period under applicable ‎securities laws in Canada. The Offering is ...

About BriaCell Therapeutics BriaCell is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. More information is available at https://briacell.com/.

Investors subscribing for Series E Preferred Stock will receive an annual 12% dividend rate, which will accrue and be paid quarterly. The Series E Preferred Stock is convertible into a new class of GH ...

At the core of Quetzal’s mission is a belief that cutting-edge science, guided by proven leadership, can redefine what’s possible in treatment for conditions like Acute Promyelocytic Leukemia (“APL”) ...

About eMI eMI Aesthetics is an innovative AI-powered platform that empowers users to explore aesthetic treatments visually, privately, and confidently. With no downloads, instant simulation, and ...

Advanced algorithms aim to reduce trial planning timelines, accelerating time-to-market for new therapies; Initiative to support Tevogen Bio’s ExacTcell™ pipeline with a goal ...